Position
EWA, LLC in C4 Therapeutics, Inc.
Back to the book · All holders of CCCC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $10.5K$1.91 → $2.63
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 16.9K | $32.3K | — | — | — | 0.0% |
| Q1 2026 | 14.6K | $38.3K | $2.63 | $10.5K | −$4.43K | 0.0% |